Literature DB >> 10396071

EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.

U Zimber-Strobl1, L Strobl, H Höfelmayr, B Kempkes, M S Staege, G Laux, B Christoph, A Polack, G W Bornkamm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10396071     DOI： 10.1007/978-3-642-60162-0_39

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  3 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 2.  Viral and cellular oncogenes promote immune evasion.

Authors:  Jessica J Roetman; Minna K I Apostolova; Mary Philip
Journal:  Oncogene       Date:  2022-01-13       Impact factor: 8.756

3.  Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.

Authors:  Sana AlQarni; Yazeed Al-Sheikh; Donald Campbell; Mark Drotar; Adele Hannigan; Shelagh Boyle; Pawel Herzyk; Andrew Kossenkov; Kate Armfield; Lauren Jamieson; Mariarca Bailo; Paul M Lieberman; Penelope Tsimbouri; Joanna B Wilson
Journal:  Oncogene       Date:  2018-04-25       Impact factor: 9.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.